1.25
-0.005(-0.40%)
Currency In USD
| Previous Close | 1.25 |
| Open | 1.24 |
| Day High | 1.26 |
| Day Low | 1.21 |
| 52-Week High | 1.8 |
| 52-Week Low | 0.91 |
| Volume | 32,610 |
| Average Volume | 143,309 |
| Market Cap | 74.05M |
| PE | -2.78 |
| EPS | -0.45 |
| Moving Average 50 Days | 1.34 |
| Moving Average 200 Days | 1.21 |
| Change | -0.01 |
If you invested $1000 in Vivani Medical, Inc. (VANI) 10 years ago, it would be worth $4.47 as of August 18, 2025 at a share price of $1.25. Whereas If you bought $1000 worth of Vivani Medical, Inc. (VANI) shares 5 years ago, it would be worth $404.53 as of August 18, 2025 at a share price of $1.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
GlobeNewswire Inc.
Aug 05, 2025 12:10 PM GMT
LIBERATE-1, the first-in-human application of Vivani’s NanoPortalTM implant technology, showed a positive safety and tolerability profile, along with encouraging performance data for NPM-115 that met the study’s primary objectives New NPM-139 (semagl
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
GlobeNewswire Inc.
Jun 11, 2025 12:00 PM GMT
ALAMEDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of
Vivani Medical to Present at the 2025 BIO International Convention
GlobeNewswire Inc.
Jun 10, 2025 12:30 PM GMT
ALAMEDA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mend